CUTTING EDGE SCIENCE FROM THE CLINICAL TRIAL TO THE BEDSIDE: FIRST 8 MONTHS USE OF DROTRECOGIN ALPHA ACTIVATED (APC) FOR SEVERE SEPSIS
Riker, Richard R, Fraser, Gilles L, Schlichting, Douglas E, Wilkins, Shelly LVolume:
30
Journal:
Critical Care Medicine
DOI:
10.1097/00003246-200212001-00352
Date:
December, 2002
File:
PDF, 1.06 MB
2002